Literature DB >> 19016772

Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma.

Hiroaki Shiba1, Yuichi Ishida, Shigeki Wakiyama, Taro Sakamoto, Takeyuki Misawa, Katsuhiko Yanaga.   

Abstract

A 77-year-old-man was admitted to hospital for treatment of a huge hepatocellular carcinoma by transarterial chemoembolization. After treatment, the patient developed acute tumor lysis syndrome with hyperkalemia, hyperuricemia, hyperphosphatemia, hypocalcemia, metabolic acidosis and acute renal failure, which was successfully treated. In the treatments of solid organ tumors, acute tumor lysis syndrome is an extremely rare complication. To the best of the authors' knowledge, this patient is the third case of such a complication after transarterial chemoembolization for a hepatocellular carcinoma in the English literature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016772     DOI: 10.1111/j.1349-7006.2008.00958.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  11 in total

Review 1.  Spontaneous tumour lysis syndrome.

Authors:  Natasha Kekre; Bojana Djordjevic; Claire Touchie
Journal:  CMAJ       Date:  2012-04-10       Impact factor: 8.262

2.  Tumour Lysis Syndrome: a Rare Complication of Trans-Arterial Chemo-Embolisation with Doxorubicin Beads for Hepatocellular Carcinoma.

Authors:  Diana Katiman; Jeeta Manikam; Khean-Lee Goh; Basri Johan Abdullah; Sanjiv Mahadeva
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 3.  Tumor lysis syndrome and primary hepatic malignancy: case presentation and review of the literature.

Authors:  Sean P Zivin; Youssef Elias; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

4.  A case of gouty arthritis following percutaneous radiofrequency ablation for hepatocellular carcinoma.

Authors:  Dae Hee Choi; Hyo-Suk Lee
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

5.  Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients.

Authors:  Zhong Ye; Juan P Palazzo; Liz Lin; Yinzhi Lai; Fran Guiles; Ronald E Myers; Jin Han; Jinliang Xing; Hushan Yang
Journal:  J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 4.029

6.  An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Authors:  Danica Maria Vodopivec; Jose Enrique Rubio; Alessia Fornoni; Oliver Lenz
Journal:  Case Rep Med       Date:  2012-05-27

7.  Tumor Lysis Syndrome after Hepatic Artery Embolization in a Patient with Neuroendocrine Tumor of Unknown Primary.

Authors:  Odeth Barrett-Campbell; Joselle Cook; Jordonna Brown; Evelyn Taiwo; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2019-06-24

8.  Balloon-Occluded Trans-Arterial Chemo-Embolization Technique with Repeated Alternate Infusion of Cisplatin Solution and Sparse Gelatin Slurry (RAIB-TACE) for Large Hepatocellular Carcinoma Nodules More than 7 cm in Diameter.

Authors:  Toshiyuki Irie; Nobuyuki Takahashi; Toshiro Kamoshida; Junya Kashimura; Hiroyuki Ariga
Journal:  Biomed Res Int       Date:  2020-01-19       Impact factor: 3.411

9.  Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma.

Authors:  Eiichiro Suzuki; Yoshihiko Ooka; Tetsuhiro Chiba; Kazufumi Kobayashi; Naoya Kanogawa; Tenyu Motoyama; Tomoko Saito; Sadahisa Ogasawara; Akinobu Tawada; Osamu Yokosuka
Journal:  Clin J Gastroenterol       Date:  2014-12-07

Review 10.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.